R&D

December 14, 2023 R&D Day 2023 Recap: Following the Science to Deliver on the Promise of RNAi Therapeutics During our 2023 R&D Day, our leadership discussed several exciting innovations and provided a look ahead at the rapid growth and evoltuion of our pipeline. Read More ›
March 10, 2023 Harnessing Human Genetics to Power the Next Wave of RNAi Therapeutics Learn about how Alnylam's approach to genetic validation and how it is using genetics to power the development of the next wave of RNAi therapeutics Read More ›
Subscribe to R&D